Notice of conference call and webcast
28 Oktober 2008 - 9:20PM
PR Newswire (US)
THIRD QUARTER 2008 FINANCIAL RESULTS Confirmation of Annual and
Special General Meeting of Shareholders VANCOUVER, Oct. 28
/PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc.
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty
pharmaceutical and medical device company, will host a conference
call discussing its financial results for the third quarter ended
September 30, 2008 on Thursday, November 6, 2008 at 11:00 AM ET
(8:00 AM Pacific). The Company's Annual and Special General Meeting
of Shareholders is confirmed for Thursday, October 30, 2008 at
11:30 AM ET (8:30 AM Pacific). Due to the proximity of the earnings
conference call, there will be no management update at the Annual
and Special General Meeting of Shareholders; and therefore, the
meeting will not be made available via webcast or conference call.
Dial information for the earnings call on November 6, 2008 is as
follows: North America (toll-free): (866) 383-7998 International:
(617) 597-5329 Enter passcode: 11247654 A live webcast of the
earnings conference call will be available to all interested
parties through Angiotech's website at http://www.angiotech.com/ in
the Investor Relations section. A press release announcing
Angiotech's financial results will be issued prior to the
conference call on November 6 at approximately 8:00 AM ET
(5:00 AM Pacific). A replay archive of the conference call
will be available until November 13, 2008. Replay information
is as follows: North America: (888) 286-8010 International: (617)
801-6888 Enter passcode: 75181409 About Angiotech Pharmaceuticals
Angiotech Pharmaceuticals, Inc. is a global specialty
pharmaceutical and medical device company with over 1,500 dedicated
employees. Angiotech discovers, develops and markets innovative
treatment solutions for diseases or complications associated with
medical device implants, surgical interventions and acute injury.
To find out more about Angiotech (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP)
please visit our website at http://www.angiotech.com/. DATASOURCE:
Angiotech Pharmaceuticals, Inc. CONTACT: DeDe Sheel, Investor
Relations and Corporate Communications, Angiotech Pharmaceuticals,
Inc., (415) 293-4412,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Okt 2023 bis Okt 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel